Biohit Oyj

Biohit Oyj Series B
Stock Exchange Nasdaq Helsinki
EPS
EUR0.14
Market Cap
EUR42.13 M
Shares Outstanding
12.07 M
Public Float
550 K

Profile

Address
Laippatie 1
Helsinki UU 00880
Finland
Employees -
Website http://www.biohithealthcare.com
Updated 07/08/2019
Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. It also offers acetaldehyde binding products, monoclonal antibodies, and instruments. The company was founded by Osmo Suovaniemi in 1988 and is headquartered in Helsinki, Finland.

Financials

View All

Osmo Antero Suovaniemi
Chairman
Feng Liu
Director